Rare diseases
Investigational molecules
Locations
Back to Germany357 clinical trials in Mannheim, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
GermanyStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
GermanyStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
GermanyStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
GermanyStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
GermanyDrug interaction study of leniolisib with a drug combination in healthy volunteers for Activated PI3K Delta Syndrome
GermanyPhase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression
GermanyEffect of iclepertin on the blood levels of ethinylestradiol and levonorgestrel in healthy premenopausal women
GermanyA Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
GermanyEffect of carbamazepine on the blood levels of BI 1810631 after a single dose in healthy men
GermanyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Alzheimer's Disease and ALS, including trials of new therapeutic compounds for early-stage dementia and innovative treatments for motor neuron disease.
Research aims to improve brain amyloid clearance and evaluate new treatment approaches for neurological disorders.
Comprehensive studies in cancer treatment, including trials for gastric cancer, melanoma, and breast cancer, with a focus on targeted therapies and immunological approaches.
Advanced treatments combining immunotherapy with established protocols to improve patient outcomes.
Studies addressing inflammatory disorders, particularly focusing on Crohn's Disease, ulcerative colitis, and uveitis, testing novel therapeutic combinations.
Innovative treatment strategies aimed at improving disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
